Daniel Addison, MD
Physician
Specialty:Cardiovascular Disease
Gender: Male
Academic Title: Associate Professor in the College of Medicine
Research Program: Cancer Control
About Me
More info forI am a clinical investigator and practicing cardiologist with unique expertise in cardiovascular imaging and cardio-oncology. I have been at The Ohio State University since 2017 following the completion of an advanced cardiovascular imaging fellowship at Massachusetts General Hospital-Harvard, where I focused in cardio-oncology. I currently serve as Director of the Cardio-Oncology Program at the OSUCCC – James, where I specifically seek to employ advanced imaging techniques to understand the pathophysiologic mechanisms and potential targets of interventions for cardiovascular disease(s) among cancer survivors at-risk for cardiovascular events. I am also an associate professor of Internal Medicine in the Division of Cardiovascular Medicine at The Ohio State University College of Medicine. I also serve in multiple imaging, cardio-oncology, and research roles. To date, my efforts focus on the interplay of cancer-treating radiotherapy and cardiovascular events, the early detection of anthracycline-associated cardiotoxicity and the early detection and mechanisms of cancer immunotherapy-associated cardiovascular disease, for which I am supported by the AHA, NCI, and other foundations.
Clinical Expertise
More info for- Internal Medicine
- Cardiovascular Diseases
Where I See Patients
More info forThe Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
460 W. 10th Ave. Columbus, Ohio 43210 800-293-5066 Location InformationEducation & Training
More info forFellowship - Cardiovascular Disease
- Baylor College of Medicine
1 Baylor Plz, Houston, TX
Internship - Internal Medicine
- Baylor College of Medicine
1 Baylor Plz, Houston, TX
Residency - Internal Medicine
- Baylor College of Medicine
1 Baylor Plz, Houston, TX
Fellowship - Advanced Cardiac Imaging
- Massachusetts General Hospital
55 Fruit St, Boston, MA
Medical School
- Meharry Medical College School of Dentistry
1005 Dr Db Todd Jr Blvd, Nashville, TN
- Baylor College of Medicine
Academic Office & Contact Information
More info forAcademic Office:
Davis Heart and Lung Research
473 W 12th Ave
Columbus, Ohio 43210-1252Email:
addison.53@osu.eduPublications
More info forOctober 17, 2024Cardiovascular Toxicities Associated with Novel Cellular Immune Therapies.
Munir M, Sayed A, Addison D, Epperla N
Blood Adv
September 1, 2024Effectiveness of mobile health for exercise promotion on cardiorespiratory fitness after a cancer diagnosis: A systematic review and meta-analysis.
Gregory ME, Cao W, Rahurkar S, Haroun F, Stock JC, Ghazi SM, Addison D
Cancer Med
August 19, 2024Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapies.
Kalathoor S, Ghazi S, Otieno B, Babcook MA, Chen S, Nidhi N, Bae J, Pierre-Charles J, Breathett K, Mazimba S, Johnson A, Brewer L, Mohammed S, Carter RR, Bonsu JM, Ferdousi M, Kola-Kehinde O, McLaughlin E, Brammer J, Ruz P, Khan S, Odei B, Mitchell D, Wei L, Patel P, Paskett ED, Addison D
Int J Cancer
August 17, 2024Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation.
Gambril JA, Ghazi SM, Sansoterra S, Ferdousi M, Kola-Kehinde O, Ruz P, Kittai AS, Rogers K, Grever M, Bhat S, Wiczer T, Byrd JC, Woyach J, Addison D
Leukemia
August 1, 2024Particulate Matter 2.5 Pollution Impact on Comorbid Cancer and Cardiovascular Disease Mortality in the U.S.
Kumar A, Khadke S, AlKindi S, Rajagopalan S, Nasir K, Kazi D, Ahmad J, Khan S, Asnani A, Addison D, Sadler D, Deswal A, Barac A, Guha A, Liu J, Lenihan D, Neilan TG, Hayek S, Hermann J, Nohria A, Dani SS, Ganatra S
JACC Adv
July 26, 2024Cardiovascular Diseases Increase Cancer Mortality in Adults: NHANES-Continuous Study.
Makram OM, Okwuosa T, Addison D, Cortes J, Dent S, Bevel M, Ganatra S, Al-Kindi S, Hedrick CC, Weintraub NL, Wang X, Guha A
J Am Heart Assoc
July 22, 2024Comparison of atrial fibrillation prevalence and in-hospital cardiovascular outcomes between patients undergoing allogeneic versus autologous hematopoietic stem cell transplantation: insights from the national inpatient sample.
Krishan S, Asad ZUA, Quiroga D, Ghazi SM, Quartermaine C, Braunstein Z, Kola-Kehinde O, Shaaban A, Habib A, Khan S, Cheng R, Brammer JE, Addison D
Sci Rep
April 22, 2024Response to: Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Noguchi et al.
Sayed A, Munir M, Poliner M, Sughra S, Epperla N, Addison D
J Immunother Cancer
March 1, 2024Association between social vulnerability index and admission urgency for transcatheter aortic valve replacement.
Bolakale-Rufai IK, Shinnerl A, Knapp SM, Johnson AE, Mohammed S, Brewer L, Torabi A, Addison D, Mazimba S, Breathett K
Am Heart J Plus
February 21, 2024Cardiovascular toxicities associated with bispecific T-cell engager therapy.
Sayed A, Munir M, Ghazi SM, Ferdousi M, Krishan S, Shaaban A, Habib A, Kola-Kehinde O, Ruz P, Khan S, Sharma S, Meara A, Mahmood S, Feldman S, Yang EH, Kim J, Epperla N, Addison D
J Immunother Cancer
February 19, 2024Cardiovascular Disease Incidence and Cardiovascular Health Among Diverse Women With Breast and Gynecologic Cancers.
Nolan TS, Sinnott JA, Krok-Schoen JL, Arthur EK, Ridgway-Limle E, Gray Ii DM, Addison D, Smith S, Williams KP, Hood DB, Joseph JJ, Felix A
Oncol Nurs Forum
February 17, 2024The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes in Patients with Cancer: A Systematic Review and Meta-Analysis.
Agarwal S, Qamar U, Fujiwara Y, Guha A, Naqash AR, Yang EH, Addison D, Barac A, Asad ZUA
Am J Cardiol
February 1, 2024Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021.
Brown SA, Beavers C, Bauer B, Cheng RK, Berman G, Marshall CH, Guha A, Jain P, Steward A, DeCara JM, Olaye IM, Hansen K, Logan J, Bergom C, Glide-Hurst C, Loh I, Gambril JA, MacLeod J, Maddula R, McGranaghan PJ, Batra A, Campbell C, Hamid A, Gunturkun F, Davis R, Jefferies J, Fradley M, Albert K, Blaes A, Choudhuri I, Ghosh AK, Ryan TD, Ezeoke O, Leedy DJ, Williams W, Roman S, Lehmann L, Sarkar A, Sadler D, Polter E, Ruddy KJ, Bansal N, Yang E, Patel B, Cho D, Bailey A, Addison D, Rao V, Levenson JE, Itchhaporia D, Watson K, Gulati M, Williams K, Lloyd-Jones D, Michos E, Gralow J, Martinez H
Am Heart J Plus
December 13, 2023Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.
Braunstein Z, Waller A, Dotson E, McLaughlin E, Hanel W, Reneau J, Addison D, Porcu P, Brammer JE
Leuk Lymphoma
December 12, 2023Exploring the Incorporation of a Novel Cardiotoxicity Mobile Health App Into Care of Patients With Cancer: Qualitative Study of Patient and Provider Perspectives.
Gregory ME, Cao W, Rahurkar S, Jonnalagadda P, Stock JC, Ghazi SM, Reid E, Berk AL, Hebert C, Li L, Addison D
JMIR Cancer
November 13, 2023The risk vs. benefit calculus of anticoagulation in patients with ibrutinib-related atrial fibrillation.
Patel R, Singh A, Meng Z, Baldridge AS, Addison D, Akhter N
Leuk Lymphoma
October 23, 2023Association Between Race, Cardiology Care, and the Receipt of Guideline-Directed Medical Therapy in Peripartum Cardiomyopathy.
Bolakale-Rufai IK, Knapp SM, Johnson AE, Brewer L, Mohammed S, Addison D, Mazimba S, Tucker-Edmonds B, Breathett K
J Racial Ethn Health Disparities
October 1, 2023Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review.
Quartermaine C, Ghazi SM, Yasin A, Awan FT, Fradley M, Wiczer T, Kalathoor S, Ferdousi M, Krishan S, Habib A, Shaaban A, Kola-Kehinde O, Kittai AS, Rogers KA, Grever M, Ruz P, Bhat S, Dickerson T, Byrd JC, Woyach J, Addison D
JACC CardioOncol
October 1, 2023Cardiotoxic Atrial Fibrillation With Novel Cancer Treatment: More Relevant Than We Think.
Addison D, Shaaban A, Habib A
JACC Adv
September 25, 2023When helping hurts: restricting cardiotoxicity of cancer therapeutics with accurate cardiovascular risk assessment works!
Baliga RR, Addison D, Lenihan DJ, Narula J, Bossone E
Eur J Prev Cardiol
August 11, 2023Incident Atrial Fibrillation and Survival Outcomes in Esophageal Cancer following Radiotherapy.
Miller ED, Wu T, McKinley G, Slivnick J, Guha A, Mo X, Prasad R, Yildiz V, Diaz D, Merritt RE, Perry KA, Jin N, Hodge D, Poliner M, Chen S, Gambril J, Stock J, Wilbur J, Pierre-Charles J, Ghazi SM, Williams TM, Bazan JG, Addison D
Int J Radiat Oncol Biol Phys
August 7, 2023The association between cardiovascular disease and breast and gynecologic cancers among black female patients.
Williams KP, Lin CJ, Felix AS, Addison D, Sheppard VB, Sutton AL, Mumma MT, Im W, Juarez PD, Hood DB
J Natl Med Assoc
May 9, 2023The Underutilization of Preventive Cardiovascular Measures in Patients with Cancer. An Analysis of the Behavioural Risk Factor Surveillance System, 2011-2022.
Sayed A, Munir M, Addison D, Abushouk AI, Dent SF, Neilan TG, Blaes A, Fradley MG, Nohria A, Moustafa K, Virani SS
Eur J Prev Cardiol
April 7, 2023Determination and disposition of meta-iodobenzylguanidine in plasma and heart of transporter-deficient mice by UPLC-MS/MS.
Talebi Z, Jin Y, Baker SD, Addison D, Sparreboom A
J Chromatogr B Biomed Sci Appl
April 1, 2023Atrial Fibrillation With Modern Cancer Treatment: More Common Than We Think.
Addison D, Quartermaine C, Brammer JE
JACC CardioOncol
February 2, 2023Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity.
Buck B, Chum AP, Patel M, Carter R, Nawaz H, Yildiz V, Ruz P, Wiczer T, Rogers KA, Awan FT, Bhat S, Guha A, Kittai AS, Simonetti OP, Raman SV, Wallace G, Sanchez R, Bonsu JM, Gambril J, Haddad D, Mann J, Wei L, Kola-Kehinde O, Byrd JC, Woyach JA, Addison D
JAMA Oncol
January 1, 2023Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survival.
Hassan MZO, Tawakol A, Wang Y, Alvi RM, Awadalla M, Jones-O'Connor M, B Bakar R, Banerji D, Rokicki A, Zhang L, Mulligan CP, Osborne MT, Zarif A, Hammad B, Chan AW, Wirth LJ, Warner ET, Pitman RK, Armstrong KA, Addison D, Neilan TG
PLoS One
January 1, 2023Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib.
Sukrithan V, Kim L, Sipos JA, Goyal A, Zhou Y, Addison D, Shah M, Konda B, Vallakati A
Case Rep Endocrinol
August 2, 2022Ventricular Arrhythmias and Sudden Death Events following Acalabrutinib initiation.
Bhat SA, Gambril JA, Azali L, Chen ST, Rosen L, Palettas M, Wiczer T, Kalathoor S, Zhao Q, Rogers KA, Kittai AS, Grever MR, Awan FT, Ruz P, Byrd JC, Woyach JA, Addison D
Blood
July 21, 2022Reply to comment on "Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: A systematic review and Bayesian network meta-analysis".
Sayed A, Abdelfattah OM, Addison D
Eur J Cancer
July 14, 2022Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation.
Chen ST, Azali L, Rosen L, Zhao Q, Wiczer T, Palettas M, Gambril J, Kola-Kehinde O, Ruz P, Kalathoor S, Rogers K, Kittai A, Grever M, Awan F, Byrd JC, Woyach J, Bhat SA, Addison D
J Hematol Oncol
July 5, 2022International Consensus Statement on the Management of Cardiovascular Risk of Bruton's Tyrosine Kinase Inhibitors in CLL.
Awan FT, Addison D, Alfraih F, Baratta SJ, Campos RN, Cugliari MS, Goh YT, Ionin VA, Mundnich S, Sverdlov AL, Tam CS, Ysebaert L
Blood Adv
July 1, 2022Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.
Gambril JA, Chum A, Goyal A, Ruz P, Mikrut K, Simonetti O, Dholiya H, Patel B, Addison D
Heart Fail Clin
June 17, 2022Length of stay and cost of care associated with admissions for atrial fibrillation among patients with cancer.
Guha A, Jain A, Aggarwal A, Dey AK, Dani S, Ganatra S, Marchlinski FE, Addison D, Fradley MG
BMC Cardiovasc Disord
June 1, 2022The intersection of gynecologic cancer, obesity, and cardiovascular disease.
Felix AS, Addison D
Gynecol Oncol
May 27, 2022Hypertensive events after the initiation of contemporary cancer therapies for breast cancer control.
Carter RR, Chum AP, Sanchez R, Guha A, Dey AK, Reinbolt R, Kim L, Otchere P, Oppong-Nkrumah O, Abraham WT, Lustberg M, Addison D
Cancer Med
May 4, 2022Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: A systematic review & bayesian network meta-analysis.
Sayed A, Abdelfattah OM, Munir M, Shazly O, Awad AK, Ghaith HS, Moustafa K, Gerew M, Guha A, Barac A, Fradley MG, Abela GS, Addison D
Eur J Cancer
March 1, 2022Cardiovascular Event Reporting in Modern Cancer Radiation Therapy Trials.
Prasad RN, McIntyre M, Guha A, Carter RR, Yildiz VO, Paskett E, Lustberg M, Ruz P, Williams TM, Kola-Kehinde O, Miller ED, Addison D
Adv Radiat Oncol
January 28, 2022The association of atrial fibrillation with mortality in patients with breast cancer: author reply.
Guha A, Alonso A, Addison D
Eur Heart J
January 1, 2022Lack of Cardiotoxicity Endpoints in Prospective Trials Involving Chest Radiation Therapy: A Review of Registered, Latter-Phase Studies.
Prasad RN, Miller ED, Addison D, Bazan JG
Front Oncol
January 1, 2022Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias.
Braunstein Z, McLaughlin E, Ruiz M, Wei L, Bumma N, Benson D, Devarakonda S, Chaudhry M, Khan A, Cottini F, Hanel W, Baiocchi R, Chung C, Addison D, Couette N, Meara A, Jarjour W, Porcu P, Mishra A, Reneau JC, Rosko AE, Brammer JE
Front Oncol
January 1, 2022Carfilzomib-induced Cardiotoxicity: An Analysis of the FDA Adverse Event Reporting System (FAERS).
Buck B, Kellett E, Addison D, Vallakati A
J Saudi Heart Assoc
December 1, 2021Assessing Silent Cardiotoxicity in Long-Term Lymphoma Survivors Treated With Radiotherapy.
Miller E, Mikrut K, Addison D
JACC CardioOncol
November 14, 2021Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.
Guha A, Fradley MG, Dent SF, Weintraub NL, Lustberg MB, Alonso A, Addison D
Eur Heart J
November 1, 2021Cardiotoxicity as an Endpoint in Prospective Clinical Trials Involving Chest Radiation Therapy.
Prasad RN, Miller ED, Addison D, Bazan JG
Int J Radiat Oncol Biol Phys
October 22, 2021Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemia.
Kim L, Fowler B, Campbell CM, Slivnick J, Nawaz H, Kaka Y, Ruz P, Vallakati A, Baliga R, Vasu S, Addison D
Cardiooncology
September 30, 2021Cardiovascular Safety Communications After US Food and Drug Administration Approval of Contemporary Cancer Therapies.
Bonsu JM, Kola-Kehinde O, Kim L, Ruz P, Campbell CM, Brammer JE, Addison D
JAMA Oncol
August 1, 2021Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma.
Brammer JE, Braunstein Z, Katapadi A, Porter K, Biersmith M, Guha A, Vasu S, Yildiz VO, Smith SA, Buck B, Haddad D, Gumina R, William BM, Penza S, Saad A, Denlinger N, Vallakati A, Baliga R, Benza R, Binkley P, Wei L, Mocarski M, Devine SM, Jaglowski S, Addison D
J Immunother Cancer
May 13, 2021Outcomes in patients with anthracycline-induced cardiomyopathy undergoing left ventricular assist devices implantation.
Guha A, Caraballo C, Jain P, Miller PE, Owusu-Guha J, Clark KAA, Velazquez EJ, Ahmad T, Baldassarre LA, Addison D, Weintraub NL, Desai NR
ESC Heart Fail
April 26, 2021Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis.
Addison D, Slivnick JA, Campbell CM, Vallakati A, Jneid H, Schelbert E
J Am Heart Assoc
April 19, 2021Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS).
Zhang KW, Reimers MA, Calaway AC, Fradley MG, Ponsky L, Garcia JA, Cullen J, Baumann BC, Addison D, Campbell CM, Ghosh AK, Lenihan DJ, Desai NR, Weintraub N, Guha A
J Urol
April 17, 2021Cardiovascular Toxicities of Androgen Deprivation Therapy.
Challa AA, Calaway AC, Cullen J, Garcia J, Desai N, Weintraub NL, Deswal A, Kutty S, Vallakati A, Addison D, Baliga R, Campbell CM, Guha A
Curr Treat Options Oncol
February 2, 2021Targeting OCT3 attenuates doxorubicin-induced cardiac injury.
Huang KM, Zavorka Thomas M, Magdy T, Eisenmann ED, Uddin ME, DiGiacomo DF, Pan A, Keiser M, Otter M, Xia SH, Li Y, Jin Y, Fu Q, Gibson AA, Bonilla IM, Carnes CA, Corps KN, Coppola V, Smith SA, Addison D, Nies AT, Bundschuh R, Chen T, Lustberg MB, Wang J, Oswald S, Campbell MJ, Yan PS, Baker SD, Hu S, Burridge PW, Sparreboom A
Proc Natl Acad Sci U S A
November 17, 2020Socio-economic Burden of Myocardial Infarction among Cancer Patients.
Guha A, Dey AK, Al-Kindi S, Miller PE, Ghosh A, Banerjee A, Lopez-Mattei J, Desai NR, Patel B, Oliveira GH, de Lima M, Fradley M, Addison D
Am J Cardiol
November 5, 2020Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer.
Sardesai S, Sukumar J, Kassem M, Palettas M, Stephens J, Morgan E, Addison D, Baliga R, Stover DG, VanDeusen J, Williams N, Cherian M, Lustberg M, Wesolowski R, Ramaswamy B
Cardiooncology
October 18, 2020Hypertensive Cardiotoxicity in Cancer Treatment-Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies-Epidemiology, Incidence, and Pathophysiology.
Chung R, Tyebally S, Chen D, Kapil V, Walker JM, Addison D, Ismail-Khan R, Guha A, Ghosh AK
J Clin Med
September 23, 2020Contemporary Understandings of Cardiovascular Disease After Cancer Radiotherapy: a Focus on Ischemic Heart Disease.
Kim L, Loccoh EC, Sanchez R, Ruz P, Anaba U, Williams TM, Slivnick J, Vallakati A, Baliga R, Ayan A, Miller ED, Addison D
Curr Cardiol Rep
September 20, 2020Cardiovascular Events Associated with Chimeric Antigen Receptor T (CAR-T) Therapy: Cross-Sectional FAERS Analysis: Cardiovascular Events with CAR-T Therapy.
Guha A, Addison D, Jain P, Gutierrez JM, Ghosh A, Roddie C, de Lima M, Al-Kindi S, Oliveira GH
Biol Blood Marrow Transplant
September 1, 2020Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States.
Guha A, Dey AK, Kalra A, Gumina R, Lustberg M, Lavie CJ, Sabik JF, Addison D
Mayo Clin Proc
July 27, 2020Cardio-Oncology in Era of the COVID-19 Pandemic and Beyond.
Addison D, Campbell CM, Guha A, Ghosh AK, Dent SF, Jneid H
J Am Heart Assoc
July 22, 2020Readmission after inferior vena cava filter placement for acute venous thromboembolism in the United States: Impact of a cancer diagnosis.
Guha A, Dey AK, McKinley G, Carter RR, Miller PE, Deshmukh AJ, Zaghlol R, Barac A, Desai NR, Addison D
J Card Surg
April 29, 2020Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors.
Gupta AK, Jneid H, Addison D, Ardehali H, Boehme AK, Borgaonkar S, Boulestreau R, Clerkin K, Delarche N, DeVon HA, Grumbach IM, Gutierrez J, Jones DA, Kapil V, Maniero C, Mentias A, Miller PS, May Ng S, Parekh JD, Sanchez RH, Teodor Sawicki K, S J M Te Riele A, Ann Remme C, London B
J Am Heart Assoc
April 22, 2020Community and Socioeconomic Factors Associated with COVID-19 in the United States: Zip code level cross sectional analysis.
Guha A, Bonsu J, Dey A, Addison D
Abstr Euro J of Hum Gen
March 3, 2020Personalized Approach to Cancer Treatment-Related Cardiomyopathy.
Slivnick J, Vallakati A, Addison D, Wallner A, Tong MS
Curr Heart Fail Rep
February 18, 2020Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies.
Bonsu JM, Guha A, Charles L, Yildiz VO, Wei L, Baker B, Brammer JE, Awan F, Lustberg M, Reinbolt R, Miller ED, Jneid H, Ruz P, Carter RR, Milks MW, Paskett ED, Addison D
J Am Coll Cardiol
February 8, 2020Contemporary Trends and Outcomes of Percutaneous and Surgical Mitral Valve Replacement or Repair in Patients With Cancer.
Guha A, Dey AK, Omer S, Abraham WT, Attizzani G, Jneid H, Addison D
Am J Cardiol
February 3, 2020The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States.
Guha A, McKinley G, Dey AK, Carter R, Miller PE, Deshmukh AJ, Zaghlol R, Barac A, Desai NR, Addison D
J Card Surg
Consulting and Related Relationships
More info forAt The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Addison has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.
- National Institutes of Health
- PeerView Institute for Medical Education
- Cleveland Clinic